Poon Christine A insider trades
Poon Christine A has filed 62 Form 4s with the SEC that we hold, for Prudential Financial INC (PRU) (Director), Sherwin Williams Co (SHW) (Director), Regeneron Pharmaceuticals, INC. (REGN) (Director) and Neurocrine Biosciences INC (NBIX) (Director). Across all of them we count 0 purchases worth $0 and 31 sales worth $46.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($4.3M). The largest single trade was a sale of 5,352 shares of Regeneron Pharmaceuticals, INC. worth $6.2M, dated 2024-08-15. The first filing on our record is dated 2021-07-07 and the latest 2026-09-14.
Prudential Financial INC (PRU)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Sherwin Williams Co (SHW)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Regeneron Pharmaceuticals, INC. (REGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-27 | S, sale reported on Form 4 | 1,737 | $1.2M | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 3,447 | $2.3M | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 2,235 | $1.5M | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 603 | $403.0K | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 2,150 | $1.4M | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 1,118 | $745.4K | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 538 | $357.9K | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 112 | $75.3K | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 100 | $66.3K | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 2,260 | $1.5M | 2021-08-31 |
| 2021-08-27 | S, sale reported on Form 4 | 700 | $465.1K | 2021-08-31 |
| 2022-08-09 | S, sale reported on Form 4 | 6,814 | $4.2M | 2022-08-11 |
| 2022-08-09 | S, sale reported on Form 4 | 8,186 | $5.1M | 2022-08-11 |
| 2023-08-23 | S, sale reported on Form 4 | 300 | $251.4K | 2023-08-25 |
| 2023-08-23 | S, sale reported on Form 4 | 1,998 | $1.7M | 2023-08-25 |
| 2023-08-23 | S, sale reported on Form 4 | 6,450 | $5.4M | 2023-08-25 |
| 2023-08-23 | S, sale reported on Form 4 | 500 | $420.5K | 2023-08-25 |
| 2023-08-23 | S, sale reported on Form 4 | 3,032 | $2.5M | 2023-08-25 |
| 2024-08-15 | S, sale reported on Form 4 | 2,368 | $2.7M | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 234 | $271.5K | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 1,012 | $1.2M | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 100 | $116.1K | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 1,560 | $1.8M | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 212 | $245.5K | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 5,352 | $6.2M | 2024-08-19 |
| 2025-10-29 | S, sale reported on Form 4 | 2,735 | $1.8M | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 650 | $424.2K | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 388 | $255.0K | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 712 | $467.4K | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 100 | $65.5K | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 1,915 | $1.3M | 2025-10-31 |
Neurocrine Biosciences INC (NBIX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1189014) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms